跳至主要内容
临床试验/ITMCTR2000003749
ITMCTR2000003749招募中1 期

Translational medicine research on new patent product dysmenorrhea treatment paste

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
16 至 40(—)
性别
Female

入选标准

  • 1. Patients who meet the diagnostic criteria of Western medicine for primary dysmenorrhea;
  • 2. TCM syndrome differentiation belongs to qi stagnation and blood stasis syndrome;
  • 3. Patients aged 16-40 years old;
  • 4. Patients with regular menstrual cycle (28 ± 7) days;
  • 5. Patients who did not take analgesics, sedatives and hormonal drugs within 2 weeks before receiving this therapy;
  • 6. Patients who sign informed consent form;
  • 7. Patients with VAS score >= 4.

排除标准

  • 1. Lactating women;
  • 2. Patients with serious life-threatening primary diseases such as cardio cerebrovascular system, liver, kidney and hematopoietic system, as well as psychosis;
  • 3. Patients who are participating in other clinical trials.

研究者

发起方
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

相似试验

Translational medicine research on new patent... | 临床试验